MAGED2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.606600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.851400E-01
Normal-vs-Stage2
9.499200E-01
Normal-vs-Stage3
8.477200E-01
Normal-vs-Stage4
9.321200E-01
Stage1-vs-Stage2
2.815000E-01
Stage1-vs-Stage3
5.071400E-01
Stage1-vs-Stage4
7.263600E-01
Stage2-vs-Stage3
7.202800E-01
Stage2-vs-Stage4
7.983200E-01
Stage3-vs-Stage4
7.632200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.633400E-01
Normal-vs-AfricanAmerican
9.770000E-01
Normal-vs-Asian
8.399400E-01
Caucasian-vs-AfricanAmerican
8.322600E-01
Caucasian-vs-Asian
9.921000E-01
AfricanAmerican-vs-Asian
7.854200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.885000E-01
Normal-vs-Female
8.307000E-01
Male-vs-Female
7.121600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.237000E-01
Normal-vs-Age(41-60Yrs)
6.615000E-01
Normal-vs-Age(61-80Yrs)
9.723000E-01
Normal-vs-Age(81-100Yrs)
6.679800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.050200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.361800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.987200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.907600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.972300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.718600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.618600E-01
Normal-vs-Daily Drinker
7.730600E-01
Normal-vs-Weekly Drinker
5.653400E-01
Normal-vs-Occasional Drinker
7.370600E-01
Normal-vs-Social Drinker
5.958800E-01
Non Drinker-vs-Daily Drinker
6.565600E-01
Non Drinker-vs-Weekly Drinker
2.066200E-02
Non Drinker-vs-Occasional Drinker
1.246190E-01
Non Drinker-vs-Social Drinker
8.533900E-02
Daily Drinker-vs-Weekly Drinker
9.817500E-02
Daily Drinker-vs-Occasional Drinker
2.205800E-01
Daily Drinker-vs-Social Drinker
1.447420E-01
Weekly Drinker-vs-Occasional Drinker
7.726400E-01
Weekly Drinker-vs-Social Drinker
8.101800E-01
Occasional Drinker-vs-Social Drinker
6.247000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.596000E-01
Normal-vs-Grade 2
8.349800E-01
Normal-vs-Grade 3
8.148000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.064200E-02
Grade 1-vs-Grade 3
5.105700E-02
Grade 1-vs-Grade 4
9.596000E-01
Grade 2-vs-Grade 3
4.388200E-01
Grade 2-vs-Grade 4
8.349800E-01
Grade 3-vs-Grade 4
8.148000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.069200E-01
Normal-vs-NonDiabetic
7.778200E-01
Diabetic-vs-NonDiabetic
1.523230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.493200E-01
Normal-vs-NoPancreatitis
8.532400E-01
Pancreatitis-vs-NoPancreatitis
8.858600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.123800E-01
Normal-vs-N1
9.659000E-01
N0-vs-N1
1.296440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.794000E-01
Normal-vs-TP53-NonMutant
7.286400E-01
TP53-Mutant-vs-TP53-NonMutant
7.116000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
